Juntendo Medical Journal
Online ISSN : 2759-7504
Print ISSN : 2187-9737
ISSN-L : 2187-9737
Safety of Platelet-rich Plasma Treatment for Oral Diseases
MORIKUNI TOBITA ANNA ARITAYOSUKE MASUBUCHIKEIKO WAKANAHIKARI YONEDASHUNSUKE NAMAKITAKAAKI TAMAGAWAMITSUYO SHINOHARA
Author information
JOURNAL OPEN ACCESS Advance online publication

Article ID: JMJ24-0054-OA

Details
Abstract

Objectives Platelet-rich plasma (PRP), obtained by centrifuging autologous blood, is widely used for pain relief and wound healing. PRP is also used in the dental field, but the safety and validity thereof for dental diseases have not yet been fully established. We aimed to evaluate the safety of PRP for the following dental procedures: post-extraction socket healing, maxillary sinus floor elevation, periodontal tissue regeneration, and intentional tooth replantation.

Materials PRP was purified from patient’s own venous blood and transplanted.

Methods Eight patients were enrolled in clinical trials targeting four dental diseases, and subjected to the required treatment with transplantation (two patients/study). The primary endpoint was safety; specifically, adverse events after PRP treatment were evaluated based on clinical observations. Secondary endpoints were clinical evaluation, dental radiography and/or imaging evaluation, and platelet count.

Results No serious adverse events associated with the PRP transplantation were observed. In tooth extraction sockets, postoperative pain tended to subside the day after treatment. Regeneration of hard tissue at the PRP transplant site has been confirmed in clinical studies on maxillary sinus lifts, periodontal tissue regeneration, and tooth replantation.

Conclusions Our findings demonstrate the safety and validity of PRP transplantation for each type of dental disease. Because the sample size was limited, further large-scale clinical studies are required to evaluate the safety and validity of PRP treatment for each dental disease.

Content from these authors
© 2025 The Juntendo Medical Society. This is an open access article distributed under the terms of Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original source is properly credited.

This article is licensed under a Creative Commons [Attribution 4.0 International] license.
https://creativecommons.org/licenses/by/4.0/
Previous article Next article
feedback
Top